These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 33931024)

  • 1. Prognostic value of ubiquitin E2 UBE2W and its correlation with tumor-infiltrating immune cells in breast cancer.
    Yuan Y; Xiao WW; Xie WH; Li RZ; Gao YH
    BMC Cancer; 2021 Apr; 21(1):479. PubMed ID: 33931024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of prostaglandin I2 synthase and its correlation with tumor-infiltrating immune cells in lung cancer, ovarian cancer, and gastric cancer.
    Dai D; Chen B; Feng Y; Wang W; Jiang Y; Huang H; Liu J
    Aging (Albany NY); 2020 May; 12(10):9658-9685. PubMed ID: 32463792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 4. Systematic analysis of the expression and prognostic value of ITPR1 and correlation with tumor infiltrating immune cells in breast cancer.
    Han B; Zhen F; Zheng XS; Hu J; Chen XS
    BMC Cancer; 2022 Mar; 22(1):297. PubMed ID: 35313846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer.
    Zhong L; Yang Z; Lei D; Li L; Song S; Cao D; Liu Y
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):169-182. PubMed ID: 32799413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.
    Gao T; Jiang B; Zhou Y; He R; Xie L; Li Y
    Front Immunol; 2024; 15():1369892. PubMed ID: 38707897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer.
    Yang WJ; Shi L; Wang XM; Yang GW
    Aging (Albany NY); 2021 Aug; 13(16):20836-20852. PubMed ID: 34461608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and structural characterization of a novel ubiquitin-conjugating enzyme E2 from Agrocybe aegeria reveals Ube2w family-specific properties.
    Qi C; Li DF; Feng L; Hou Y; Sun H; Wang DC; Liu W
    Sci Rep; 2015 Nov; 5():16056. PubMed ID: 26525192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
    Wen WX; Leong CO
    PLoS One; 2019; 14(4):e0215381. PubMed ID: 31022191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
    Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients.
    Cai H; Chen H; Huang Q; Zhu JM; Ke ZB; Lin YZ; Zheng QS; Wei Y; Xu N; Xue XY
    Pathol Oncol Res; 2021; 27():1609941. PubMed ID: 34776794
    [No Abstract]   [Full Text] [Related]  

  • 13. UBE2W down-regulation promotes cell apoptosis and correlates with hypospermatogenesis.
    Lei B; Xie L; Zhang S; Lv D; Shu F; Deng Y
    Andrologia; 2020 Feb; 52(1):e13474. PubMed ID: 31710394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of ubiquitin E2 Ube2w rescues hypersensitivity of Rnf4 mutant cells to DNA damage.
    Maure JF; Moser SC; Jaffray EG; F Alpi A; Hay RT
    Sci Rep; 2016 May; 6():26178. PubMed ID: 27185577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin.
    Wang B; Zeng L; Merillat SA; Fischer S; Ochaba J; Thompson LM; Barmada SJ; Scaglione KM; Paulson HL
    Neurobiol Dis; 2018 Jan; 109(Pt A):127-136. PubMed ID: 28986324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironment.
    Bai F; Jin Y; Zhang P; Chen H; Fu Y; Zhang M; Weng Z; Wu K
    Aging (Albany NY); 2019 Nov; 11(21):9328-9347. PubMed ID: 31715586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.
    Ueki T; Park JH; Nishidate T; Kijima K; Hirata K; Nakamura Y; Katagiri T
    Cancer Res; 2009 Nov; 69(22):8752-60. PubMed ID: 19887602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis identifies AQP9 correlates with immune infiltration and acts as a prognosticator in multiple cancers.
    Liu X; Xu Q; Li Z; Xiong B
    Sci Rep; 2020 Nov; 10(1):20795. PubMed ID: 33247170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCARB2 associates with tumor-infiltrating neutrophils and predicts poor prognosis in breast cancer.
    Zhang D; Fang J; Shan J; Xu L; Wu Y; Lu B; Zhang X; Wang C; Sun P; Wang Q
    Breast Cancer Res Treat; 2024 Aug; 207(1):15-24. PubMed ID: 38914918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTN3A2 serves as a prognostic marker and favors immune infiltration in triple-negative breast cancer.
    Cai P; Lu Z; Wu J; Qin X; Wang Z; Zhang Z; Zheng L; Zhao J
    J Cell Biochem; 2020 Mar; 121(3):2643-2654. PubMed ID: 31692043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.